WEHI-539 hydrochloride
CAS: 2070018-33-4
Ref. 3D-VHD01833
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |
Produktinformation
WEHI-539 hydrochloride is a monoclonal antibody that is being developed as a tumor treatment. The antibody binds to c-Jun and inhibits the phosphorylation of this protein. This inhibition leads to decreased activation of the Jun N-terminal kinase (JNK) signaling pathway and reduced tumor growth. WEHI-539 hydrochloride has been shown to reduce tumor size in animal models, but it does not affect normal cells. It also reduces the production of growth factors that are involved in cancer cell proliferation. WEHI-539 hydrochloride has been shown to be effective against colorectal adenocarcinoma, but not against other types of tumors such as prostate cancer or breast cancer.
WEHI-539 hydrochloride is used in conjunction with statins, which inhibit cholesterol synthesis and have anti-inflammatory properties, and diode laser therapy, which can induce apoptosis by damaging DNA.
Chemische Eigenschaften
Technische Anfrage zu: 3D-VHD01833 WEHI-539 hydrochloride
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.